ロード中...
Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers
Twice‐daily sustained‐release (SR) paracetamol (acetaminophen) offers convenient administration to chronic users. This study investigated at steady state (during the last 24 hours of a 3‐day dosing period) the pharmacokinetics, bioequivalence, and safety of twice‐daily SR paracetamol compared with e...
保存先:
| 出版年: | Clin Pharmacol Drug Dev |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6084369/ https://ncbi.nlm.nih.gov/pubmed/28815997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.369 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|